Class 4 Caution in use- Various products

Recalls and Alerts

Class 4 Caution in Use

Class 4 Caution in use- Various products

Cipla (EU) Limited, UK and Pharmathen S.A. have informed the MHRA that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription Only Medicine (POM).

MHRA drug alert date: 13th July 2023

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-cipla-uk-limited-and-pharmathen-s-dot-a-various-products-el-23-a24?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b6c0ae7e-abfa-4f60-9c6b-067b05d5984f&utm_content=immediately

Pip code	Product Description	Affected Batches
4040606	SEREFLO INH 25MCG/250MCG (GB)	SEE MHRA LINK
ALLIANCE HEALTHCARE DO NOT STOCK	Kelhale 100 micrograms	SEE MHRA LINK
ALLIANCE HEALTHCARE DO NOT STOCK	Kelhale 50 micrograms	SEE MHRA LINK
ALLIANCE HEALTHCARE DO NOT STOCK	ICATIBANT PFS 30MG	SEE MHRA LINK
ALLIANCE HEALTHCARE DO NOT STOCK	Grepid 75 mg film coated tablets	SEE MHRA LINK

This is a caution in use only we are not accepting stock returns

Further Information

Cipla (UK) Limited

For more information regarding Cipla (EU) Limited, UK products, medical or supply enquiries, please contact telephone: +44 (0) 800 047 2144 or via email: drugsafety@Cipla.com & Uk.info@Cipla.com

Pharmathen S.A

For more information regarding Pharmathen S.A products, medical or supply enquiries, please contact telephone: +30 210 6604300 or via email: pharmacovigilance@pharmathen.com & info@pharmathen.com